[Event Report] Second Forum: The Introduction of Cost-Effectiveness Assessment, Its Impact, and Compatibility with Other Systems (September 13, 2018)
date : 10/2/2018
Tags: Future of the Health Care System, Innovation and Sustainability
HGPI convened the Second Forum “The Introduction of Cost-Effectiveness Assessment, Its Impact, and Compatibility with Other Systems” on September 13, 2018.
Based on the issues raised at the preparatory meeting “Rebalancing Healthcare Systems: Innovation and Sustainability Series – Issues Identified from the Trial Introduction of Cost-Effectiveness Assessment” held on May 31, we identified three key themes (technical issues, issues for institutionalization, and public understanding) to be discussed in FY2018 and have been conducting a series of forums.
In this meeting, a roundtable discussion on HTA implementation was held with experts from industry, government, academia, and civil society. The discussions included policy functions required for the future implementation of Cost-Effectiveness Assessment, as well as its impact on the current healthcare and drug pricing systems.
The next forum is scheduled as follows:
- The Third Forum (November): Public Understanding
– Increasing Public Awareness and Understanding on the Impacts and Benefits of Cost-Effectiveness Assessment –
Organizer: HGPI
Participants: Policymakers, representatives from the government, academia and private sectors
Opening (Explanatory introduction)
- Ryoji Noritake (President, HGPI)
Roundtable Discussions “The Introduction of Cost-Effectiveness Assessment, Its Impact, and Compatibility with Other Systems”
Roundtable Speakers (Titles omitted, in Japanese syllabary order)
- Shunya Ikeda (Professor, Graduate School of Medicine/Public Health, International University of Health and Welfare)
- Yoshie Onishi (Director, Japan Operations, Creativ-Ceutical K.K.)
- Kosuke Kato (Managing Director, Edwards Lifesciences Limited)
- Isao Kamae (Project Professor, Graduate School of Public Policy, the University of Tokyo).
- Keiji Kono (Senior Vice President, Global Health Policy, External Affairs, Chugai Pharmaceutical Co., Ltd.)
- Shigekazu Komoto (Planning Officer, Medical Economics Division, Health Insurance Bureau, Ministry of Health, Labour and Welfare (MHLW))
- Naokazu Saito (Chief, Policy Intelligence Division, Integrated Market Access Department, Janssen Pharmaceutical K.K.)
- Hiroyuki Sakamaki (Professor, School of Management, Tokyo University of Science)
- Naomi Sakurai (President, Cancer Solutions Co., Ltd.)
- Tomoyuki Takura (Project Professor, Department of Healthcare Economics and Health Policy, Graduate School of Medicine and Faculty of Medicine, the University of Tokyo)
- Toshio Nagase (Director, Government Affairs, Gilead Science K.K.)
- Hiroshi Nakamura (Professor, Graduate School of Business Administration, Keio University)
- Yoshiyuki Majima (President, Pancreatic Cancer Action Network Japan)
Moderator
- Joji Sugawara (Associate, HGPI)
Since 2016, HGPI has conducted a series of expert meetings entitled “Rebalancing Healthcare Systems: Innovation and Sustainability” to facilitate open discussions on HTA. Throughout these meetings, we have worked to identify the issues and to provide policy recommendations. For the past activities, please refer to the “Activity Report – Special Edition on Innovation and Sustainability” (attached below).
日本語
Top Research & Recommendations Posts
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Publication Report] Guidance on Patient and Public Involvement (PPI) in Health Policymaking: Necessary Initiatives and Good Examples from the Public and Government (March 31, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Research Report] Healthcare DX Project Research Report of Interviews ”Expectations for the Coming Era of Healthcare DX from People Living with Health Concerns” (June 10, 2024)
- [Policy Recommendations] Recommendation for the Basic Policy on Economic and Fiscal Management and Reform 2024 (June 11, 2024)
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [Public Comment Submission] Web based consultations on NCDs and mental health by World Health Organization (June 25, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
Featured Posts
-
2024-06-21
[Event Report] HGPI Special Seminar – HGPI Celebrates its 20th Anniversary: Reflecting on HGPI’s Journey from the Past to the Future (January 16, 2024)
-
2024-06-25
[Public Comment Submission] Web based consultations on NCDs and mental health by World Health Organization (June 25, 2024)
-
2024-06-26
[Event Report] Global Expert Meeting “Innovation in Cancer Care in Developing Countries ~City Cancer Challenge Initiatives“ (June 20, 2024)
-
2024-06-26
[Registration Open] (Webinar) The 127th HGPI Seminar: Current Issues and Future Prospects in Establishing a Health System and Protecting Public Health Through Policy (July 18, 2024)
-
2024-07-01
[Registration Open] Meaningful Involvement Promotion Project Online Expert Meeting “Shaping the Future of Health Policy with People with Lived Experience and Citizens” (July 26, 2024)